Click for St. Louis, Missouri Forecast

// a href = ./ // St Louis News, Weather, Sports, The Big 550 AM, St Louis Traffic, Breaking News in St Louis

 
 
 
Wednesday, 12 February 2014 12:38

Missouri death row inmate suing Oklahoma pharmacy

OKLAHOMA CITY (AP) - A Missouri inmate scheduled for execution this month is asking a federal judge to bar a Tulsa compounding pharmacy from providing the drug to be used in his lethal injection.
 
Michael Taylor's lawsuit alleges that the Missouri Department of Corrections contracted with The Apothecary Shoppe to provide compounded pentobarbital for his Feb. 26 execution.
 
The lawsuit, filed Tuesday in Tulsa federal court, alleges the drug could cause "an unnecessarily long and inhumane execution" for Taylor, who was sentenced to die for the 1989 rape and stabbing death of a 15-year-old girl.
 
A pharmacy spokeswoman did not immediately return a call seeking comment Wednesday. In a statement last month, The Apothecary Shoppe would neither confirm nor deny that it provided pentobarbital for a Missouri execution held Jan. 29.
Published in Local News

   JEFFERSON CITY, Mo. (AP) - Missouri Attorney General Chris Koster says more than $600,000 has been recovered for the Missouri Medicaid program as part of a national settlement against the drug-maker Amgen Inc.

   Amgen agreed last month to pay $24.9 million to resolve claims it gave kickbacks to increase sales of its anemia drug Aranesp. Missouri was among several states that accused Amgen of a scheme aimed at inducing nursing home professionals to dispense Aranesp over competing drugs. Missouri's share is $603,493.

   Aranesp is one of Amgen's biggest-selling drugs, though sales have fallen sharply since 2007 because of a series of safety problems and restrictions on its use.

   In December, Amgen agreed to pay $762 million to resolve federal litigation accusing it of marketing Aranesp for unapproved uses.

   

 
Published in Local News

Latest News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Prev Next

Doctors: Too few cancer patients enroll in studies

One of every 10 clinical trials for adults with cancer ends prematurely because researchers can't get enough people to test new treatments, scientists report.   The...

STL Co. offering free flu shots

STL Co. offering free flu shots

Flu season is upon us, and health officials say St. Louis County is being hit hard.  More than 800 flu cases have already been reported in the county and almost half the vi...

GROUPS RACE TO HIRE, TRAIN 'OBAMACARE' GUIDES

GROUPS RACE TO HIRE, TRAIN 'OBAMACARE' GUIDES

CHICAGO (AP) -- With the program known as "Obamacare" only weeks away from its key launch date, hectic preparations are in motion in communities across the country to deal with one...

WHAT YOU NEED TO KNOW ABOUT MARCH HEALTH DEADLINE

WHAT YOU NEED TO KNOW ABOUT MARCH HEALTH DEADLINE

WASHINGTON (AP) -- Sick of hearing about the health care law? Plenty of people have tuned out after all the political jabber and website woes. But now is the time to tun...

FRENCH DRUGMAKER WARNS ON MORNING-AFTER PILL

PARIS (AP) -- A French contraceptive maker said Tuesday its morning-after pill doesn't work when taken by women who weigh more than 80 kilograms (176 pounds) and plans to change...

NEW LYME DISEASE ESTIMATE: 300,000 CASES A YEAR

NEW LYME DISEASE ESTIMATE: 300,000 CASES A YEAR

ATLANTA (AP) -- Lyme disease is about 10 times more common than previously reported, health officials said Monday. As many as 300,000 Americans are actually diagnosed with Lyme ...

Polio-like illness a mystery in California

Polio-like illness a mystery in California

   LOS ANGELES (AP) — A polio-like illness has afflicted a small number of children in California since 2012, causing severe weakness or rapid paralysis in one or more...

PFIZER REPORTS PROMISING RESULTS FOR CANCER DRUG

PFIZER REPORTS PROMISING RESULTS FOR CANCER DRUG

WASHINGTON (AP) -- An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday....

© 2013 KTRS All Rights Reserved